We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSIBW
11676
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$41K ﹤0.01%
412,328
– –
BDSX icon
11677
Biodesix
BDSX
$253M
$40K ﹤0.01%
1,581
+201
+15% +$7.75K
CLSD
11678
CALL
DELISTED
Clearside Biomedical
CLSD
$40K ﹤0.01%
2,380
-553
-19% -$12.1K
CHRN
11679
PUT
ChronoScale Holdings
CHRN
$3.04B
$40K ﹤0.01%
1,693
+813
+92% +$24K
LSAK icon
11680
CALL
Lesaka Technologies
LSAK
$407M
$40K ﹤0.01%
11,500
-1,500
-12% -$7.56K
ORIC icon
11681
Oric Pharmaceuticals
ORIC
$1.44B
$40K ﹤0.01%
12,437
-187,950
-94% -$752K
OSS icon
11682
CALL
One Stop Systems
OSS
$339M
$40K ﹤0.01%
+12,500
New +$47.4K
OTLK icon
11683
Outlook Therapeutics
OTLK
$141M
$40K ﹤0.01%
1,640
+1,112
+211% +$25.9K
PLUR icon
11684
CALL
Pluri
PLUR
$17.3M
$40K ﹤0.01%
6,338
+1,413
+29% +$11.3K
URG
11685
Ur-Energy
URG
$537M
$40K ﹤0.01%
36,864
+22,084
+149% +$26.2K
ENZ
11686
DELISTED
Enzo Biochem, Inc.
ENZ
$40K ﹤0.01%
18,191
-10,274
-36% -$24.8K
GMDA
11687
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$40K ﹤0.01%
+25,350
New +$57.8K
MIMO
11688
DELISTED
Airspan Networks Holdings Inc
MIMO
$40K ﹤0.01%
+20,127
New +$56.5K
CDZI icon
11689
Cadiz
CDZI
$294M
$39K ﹤0.01%
20,544
-37,146
-64% -$125K
CIA icon
11690
Citizens
CIA
$201M
$39K ﹤0.01%
11,867
-25,603
-68% -$97.2K
HBIO icon
11691
Harvard Bioscience
HBIO
$30.3M
$39K ﹤0.01%
1,524
-13,370
-90% -$442K
MMLP icon
11692
Martin Midstream Partners
MMLP
$93.9M
$39K ﹤0.01%
+11,501
New +$45.6K
QNRX
11693
Quoin Pharmaceuticals
QNRX
$10.2M
$39K ﹤0.01%
42
+38
+950% +$78.2K
SGLY icon
11694
PUT
Singularity Future Technology
SGLY
$4.41M
$39K ﹤0.01%
111
-63
-36% -$28.5K
SNOA icon
11695
Sonoma Pharmaceuticals
SNOA
$6.22M
$39K ﹤0.01%
918
-366
-29% -$21.4K
SUP
11696
PUT
DELISTED
Superior Industries International
SUP
$39K ﹤0.01%
12,800
-8,800
-41% -$38.8K
BRSH
11697
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
$39K ﹤0.01%
+1,533
New +$64.8K
LMDX
11698
DELISTED
LumiraDx Limited Common Shares
LMDX
$39K ﹤0.01%
+38,718
New +$64.2K
HALL
11699
CALL
DELISTED
Hallmark Financial Services, Inc.
HALL
$39K ﹤0.01%
+3,710
New +$67.6K
EAR
11700
PUT
DELISTED
Eargo, Inc. Common Stock
EAR
$39K ﹤0.01%
1,840
-440
-19% -$11.9K
466 467
468
469 470

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.